Abstract:
PURPOSE: Provided is DNA sequence that codes variable region of an antibody having enzymatic activity degrading glycosidic bond. And its expression method is also provided. CONSTITUTION: A DNA sequence coding variable region of an antibody having enzymatic activity degrading glycosidic bond is as follows: DNA sequence represented by sequence ID. No. 1 coding VH chain of antibody for glycosidase, 4f4r; DNA sequence represented by sequence ID. No. 3 coding VH chain of antibody for glycosidase, 6h4h; DNA sequence represented by sequence ID. No. 5 coding VH chain of antibody for glycosidase, Ab2l; DNA sequence represented by sequence ID. No. 7 coding antibody for glycosidase, 4f4r; DNA sequence represented by sequence ID. No. 9 coding VL chain of antibody for glycosidase, 6h4h; or DNA sequence represented by sequence ID. No. 11 coding VL chain of antibody for glycosidase, Ab2l. Wherein, all sequences are described as in the description. The antibody is prepared by expressing a fusion protein of VH and VL in an eukaryote cell or bacteria.
Abstract:
PURPOSE: Provided is a method of selecting new target mRNA from mRNA libraries by using affinity selection to identify new mRNA easily and rapidly by using human genome gene. CONSTITUTION: The method of selecting new target mRNA from mRNA libraries by using affinity selection comprises the steps of: selecting mRNAs having specific affinity to a target compound from an RNA library using SELEX; and conforming mRNA specific to an abnormal cell by hybridizing the selected mRNAs with normal cell DNA or on a DNA chip where normal cell cDNA.
Abstract:
The present invention relates to heterodimeric conjugates of neomycin-chloramphenicol, of formula 1, their preparation and their use. Because of their heterodmieric structure, they can recognize both stem and loop of RNA motif and show binding ability to a certain RNA such that they have an enhanced pharmaceutical efficacy and reduced side effect which can be caused by non-specific drugs. For these reasons, they can be effectively used as an antiviral agent, an antibacterial agent or an anticancer drugs.
Abstract:
본발명은 생체내 세포간 신호 전달, 또는 병원체의 숙주세포 인식에 중요한 sLeX라는 4당류에 접합하는 펩타이드분자, 및 상기 펩타이드를 연속적인 모티브로 가지며 시알릴 루이스 엑스에 특이적으로 결합하는 단백질을 찾는데 상기 펩타이드분자를 사용하는 방법을 제공한다. 당을 인식하는 일열구조의 펩타이드 반복 모티프는 여러 가지 병원체의 감염억제, 백신의 개발, 또는 당-표적자 인식 분자로서, 효과적인 치료제로 이용할 수 있다.
Abstract:
PURPOSE: Provided is a heterodimer of neomycin and chloramphenicol with improved specificity to a target RNA molecule to increase the medicinal efficacy while decreasing adverse effects due to the non-specific drugs. It is effectively used as an anti-virus agent, an anti-bacteria agent, or an anti-cancer agent. CONSTITUTION: A heterodimer(formula 1) of neomycin and chloramphenicol is structured such that the heterodimer is specific-coupled to 16S rRNA, RRE RNA, or TS RNA. In the formula(1), n is an integer of 2-10 and, more particularly, 3, 6 or 9. The specific coupling of the heterodimer to the RNA is characterized by simultaneously recognizing the stem and the loop of the RNA. The specific coupling is intrinsic to the sequence of RNA.
Abstract:
The present invention relates to novel oxazolidinone derivatives represented as following compound I and a process for the preparation thereof. The compounds of the present invention have wide antibacterial spectrums superior antibacterial activity and low toxicity. Therefore, it can be expected to use as novel antibacterial agent. wherein, R 1 is alkylcarboxyl group or -CH 2 R 2 (wherein, R 2 is OH, argido group, -OR 3 (wherein, R 3 is C 1-4 alkyl, methansulfonyl, p-toluensulfonyl, carboxyl, C 1-4 alkylcarboxyl, C 1-4 alkylcarbonyl, benzyloxycarbonyl, or imidazolylcarbonyl), or -NHR 4 ).
Abstract translation:本发明涉及下述化合物I所代表的新型恶唑烷酮衍生物及其制备方法。 本发明的化合物具有优异的抗菌活性和低毒性的广谱抗菌谱。 因此,可以期待用作新型抗菌剂。 其中R SUB 1 1是烷基羧基或-CH 2 SUB 2 R SUB 2 SUB(其中,R SUB 2 2 SUB是 OH,Argido基团,-OR SUB 3(其中,R SUB 3是SUB 1-4烷基,甲磺酰基,对甲苯磺酰基, 羧基,C 1-4亚烷基羧基,C 1-4亚烷基羰基,苄氧基羰基或咪唑基羰基)或-NHR SUB 4 / SUB)。
Abstract:
The present invention relates to carbohydrate-specific peptides, which have a strong affinity and preparation method thereof. Particularly, the present invention relates to carbohydrate-specific peptides, which have been developed to have an increased strong affinity to carbohydrates by the multiple combinations of peptides having carbohydrates-specific amino acid sequences and preparation method thereof. Carbohydrate-specific peptides of the present invention have a very strong affinity under micromol, so that they can shut off recognition between cells transferred by specific carbohydrates, which means they can be used for the treatment of diseases mediated by recognition between cells and used as a diagnostic kit which diagnoses diseases by confirming the existence of any specific carbohydrate.
Abstract:
PURPOSE: Provided is a heterodimeric conjugate of neomycin-oxazolidinone which is useful as an antiviral agent and an antibacterial agent. Also, provided are the preparation method and use thereof. CONSTITUTION: A heterodimeric conjugate of neomycin-oxazolidinone is represented by the formula(1), wherein n is an integer of 2-10 and Ac represents an acetyl group. It is characterized by specifically bonding to 16S rRNA, RRE, RNA or 23S rRNA.
Abstract:
PURPOSE: Provided is a method of selecting new target mRNA from mRNA libraries by using affinity selection to identify new mRNA easily and rapidly by using human genome gene. CONSTITUTION: The method of selecting new target mRNA from mRNA libraries by using affinity selection comprises the steps of: selecting mRNAs having specific affinity to a target compound from an RNA library using SELEX; and conforming mRNA specific to an abnormal cell by hybridizing the selected mRNAs with normal cell DNA or on a DNA chip where normal cell cDNA.
Abstract:
PURPOSE: Provided are carbohydrate-specific peptides which have a strong affinity and a preparation method thereof. In particular, the carbohydrate-specific peptides are prepared by the multiple bond of peptides having a carbohydrate-specific sequence to increase an affinity. CONSTITUTION: The carbohydrate-specific peptides which have a strong affinity is characteristically prepared by the steps of; finding out peptides, which bind to carbohydrates, on the surface of a cell; and preparing peptides having a strong affinity to carbohydrates being on the surface of a cell by manufacturing a polymer of the peptides, wherein the polymer is manufactured by linking an amino acid having at least two amino residues to a peptide.